Use of Pharmacoepidemiology to Understand Predictors and Impact of Low-level Viremia in Persons with HIV in West Africa
The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).
Funding Fogarty Program
Emerging Global Leader
Project Information in NIH RePORTER
Use of Pharmacoepidemiology to Understand Predictors and Impact of Low-level Viremia in Persons with HIV in West Africa
Principal Institution
Nigerian Institute of Medical Research
Principal Investigator(s) (PI)
Herbertson, Ebiere Clara
Project Contact Information
Email:
ebiereh@yahoo.com
Year(s) Awarded
2023-2028
Country
Nigeria
Project Description
Persistent low-level viremia (LLV) in persons with HIV who are on antiretroviral therapy (ART) is a barrier to achieving the goal of zero transmission and eradication of HIV, but not much is known about the impact of LLV on attaining the ART goal of viral suppression in West Africa. The proposed research will use pharmacoepidemiologic methods to assess the prevalence of LLV and impact on ART outcomes. The study will also use mathematical modeling to predict future LLV with adherence to ART measured by innovative pharmacological techniques.
Related World Regions / Countries
Related Global Health Research Topics